MedDataX Logo

Telmisartan+HCTZ (Hydrochlorothiazide), Hypertension

NCT ID: NCT00659607

Last Updated: 2014-06-06

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

6901 participants

Study Classification

OBSERVATIONAL

Study Start Date

2003-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This Post Marketing Surveillance (PMS) study aims to review the followings by investigating the actual practice of MicardisPlus Tablet on the market:

1. Unexpected adverse drug reactions (especially, serious adverse events (SAEs))
2. Frequency of incidence and its change in adverse events (AEs)
3. Factors on the safety profile of the study drug
4. Factors on the efficacy profile of the study drug

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

An Observational Study to Investigate the Efficacy, Safety, Tolerability and the Effect on Quality of Life of Telmisartan (Micardis) and Telmisartan With HCTZ (Micardis Plus) in Patients With Hypertension

NCT00904215

Hypertension
COMPLETED

Post Marketing Surveillance (PMS) Study to Assess Safety and Efficacy of Micardis in Patients With Essential Hypertension

NCT02245464

Hypertension
COMPLETED

Study to Evaluate the Trough and Peak Effect of Once Daily Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg (Micardis Plus) by Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Essential Hypertension

NCT00257491

Hypertension
COMPLETED PHASE3

Micardis® in Patients With Essential Hypertension

NCT02187705

Hypertension
COMPLETED

Efficacy and Safety of Chronic Administration of Telmisartan as Monotherapy or in Combination With Hydrochlorothiazide or Other Antihypertensive Medications in Patients With Mild to Moderate Hypertension

NCT02177422

Hypertension
COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

patients diagnosed with essential hypertension

Exclusion Criteria

patients who took Micardis Plus before participating in this PMS study
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Boehringer Ingelheim

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Boehringer Ingelheim

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Boehringer Ingelheim

Role: STUDY_CHAIR

Boehringer Ingelheim

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Boehringer Ingelheim Investigational Site 10

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 11

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 12

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 13

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 14

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 15

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 16

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 17

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 18

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 19

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 1

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 20

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 21

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 22

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 23

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 24

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 25

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 26

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 27

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 28

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 29

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 2

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 30

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 31

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 32

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 33

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 34

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 35

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 36

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 37

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 38

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 39

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 3

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 40

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 41

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 42

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 43

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 44

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 45

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 46

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 47

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 48

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 49

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 4

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 5

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 6

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 7

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 8

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 9

Busan, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 10

Daegu, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 11

Daegu, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 12

Daegu, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 13

Daegu, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 14

Daegu, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 15

Daegu, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 16

Daegu, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 17

Daegu, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 18

Daegu, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 19

Daegu, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 1

Daegu, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 20

Daegu, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 21

Daegu, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 22

Daegu, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 23

Daegu, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 24

Daegu, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 25

Daegu, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 26

Daegu, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 27

Daegu, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 2

Daegu, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 3

Daegu, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 4

Daegu, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 5

Daegu, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 6

Daegu, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 7

Daegu, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 8

Daegu, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 9

Daegu, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 10

Daejeon, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 11

Daejeon, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 12

Daejeon, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 13

Daejeon, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 14

Daejeon, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 15

Daejeon, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 16

Daejeon, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 17

Daejeon, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 18

Daejeon, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 19

Daejeon, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 1

Daejeon, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 20

Daejeon, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 21

Daejeon, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 22

Daejeon, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 23

Daejeon, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 24

Daejeon, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 25

Daejeon, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 26

Daejeon, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 27

Daejeon, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 28

Daejeon, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 29

Daejeon, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 2

Daejeon, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 30

Daejeon, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 31

Daejeon, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 3

Daejeon, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 4

Daejeon, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 5

Daejeon, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 6

Daejeon, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 7

Daejeon, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 8

Daejeon, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 9

Daejeon, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 10

Gangwondo, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 11

Gangwondo, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 12

Gangwondo, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 13

Gangwondo, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 1

Gangwondo, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 2

Gangwondo, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 3

Gangwondo, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 4

Gangwondo, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 5

Gangwondo, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 6

Gangwondo, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 7

Gangwondo, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 8

Gangwondo, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 9

Gangwondo, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 10

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 11

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 12

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 13

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 14

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 15

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 16

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 17

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 18

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 19

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 1

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 20

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 21

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 22

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 23

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 24

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 25

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 26

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 27

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 28

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 29

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 2

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 30

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 31

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 32

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 33

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 34

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 35

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 36

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 37

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 38

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 39

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 3

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 40

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 41

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 42

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 43

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 4

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 5

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 6

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 7

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 8

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 9

Gwangju, , South Korea

Site Status

Boehringer Ingelheim Investigational Site

Gyeongbuk, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 10

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 11

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 12

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 13

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 14

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 15

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 16

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 17

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 18

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 19

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 1

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 20

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 21

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 22

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 23

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 24

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 25

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 26

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 27

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 28

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 29

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 2

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 30

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 31

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 32

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 33

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 34

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 35

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 36

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 37

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 38

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 39

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 3

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 40

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 41

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 42

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 43

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 44

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 45

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 46

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 47

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 48

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 49

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 4

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 50

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 51

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 52

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 53

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 54

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 55

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 56

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 57

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 58

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 59

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 5

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 60

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 61

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 62

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 63

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 64

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 65

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 66

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 67

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 68

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 69

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 6

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 70

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 71

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 7

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 8

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 9

Gyeonggido, , South Korea

Site Status

Boehringer Ingelheim Investigational Site

Gyeongnam, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 1

Incheon, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 2

Incheon, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 3

Incheon, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 4

Incheon, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 5

Incheon, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 6

Incheon, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 7

Incheon, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 8

Incheon, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 9

Incheon, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 1

Jeju City, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 2

Jeju City, , South Korea

Site Status

Boehringer Ingelheim Investigational Site

Jeonbuk, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 1

Jeonnam, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 2

Jeonnam, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 3

Jeonnam, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 1

Jungnam, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 2

Jungnam, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 10

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 11

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 12

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 13

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 14

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 15

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 16

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 17

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 18

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 19

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 1

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 20

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 21

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 22

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 23

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 24

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 25

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 26

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 27

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 28

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 29

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 2

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 30

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 31

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 32

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 33

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 34

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 35

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 36

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 37

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 38

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 39

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 3

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 40

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 41

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 42

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 43

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 44

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 45

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 46

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 47

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 48

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 49

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 4

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 50

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 51

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 52

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 53

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 54

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 55

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 56

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 57

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 58

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 59

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 5

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 60

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 61

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 62

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 63

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 64

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 65

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 66

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 67

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 68

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 69

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 6

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 70

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 71

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 72

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 73

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 7

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 8

Seoul, , South Korea

Site Status

Boehringer Ingelheim Investigational Site 9

Seoul, , South Korea

Site Status

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

502.475

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Relative Bioavailability of Telmisartan and HCTZ in Two Experimental Formulations Compared to the Standard Formulation Telmisartan and HCTZ in Healthy Female and Male Subjects
NCT02262572 COMPLETED PHASE1
Nice Morning- Safety and Efficacy Observational Study of Telmisartan in Hypertensive Patients in Multicenters
NCT00615108 COMPLETED
Post-Marketing Surveillance of Micardis® (Telmisartan) in Patients With Hypertension
NCT02242838 COMPLETED
Evaluation of Efficacy and Tolerability of Micardis® / MicardisPlus® Under Usual Daily-practice Prescribing in Patients With Hypertension
NCT02242383 COMPLETED
Effectiveness of MICARDIS® (Telmisartan) on Blood Pressure Control and Quality of Live in Patients With Essential Hypertension
NCT02242370 COMPLETED PHASE4
Evaluation of the Effect of Telmisartan (Micardis® 80 mg/ MicardisPlus® 80/12.5 mg) on Blood Pressure and Cardiovascular Risk Factor Index in High Risk Hypertensive Patients
NCT00904371 COMPLETED
Efficacy and Safety of the Angiotensin II Receptor Antagonist Micardis® (Telmisartan) or Hydrochlorothiazide in the Management of Patients With Isolated Systolic Hypertension (ISH)
NCT02175355 COMPLETED PHASE3
Telmisartan (Micardis) and Amlodipine (Norvasc) - Factorial Design Study for the Treatment of Hypertension
NCT00281580 COMPLETED PHASE3
Telmisartan Compared to Losartan + Hydrochlorothiazide in Patients With Mild-to-moderate Essential Hypertension
NCT02183701 COMPLETED PHASE3
A Randomized, Double-blind, Parallel-group Assessment of the Safety and Efficacy of Telmisartan 40mg Plus Hydrochlorothiazide 12.5mg (Micardis Plus) in Comparison With Losartan 50mg Plus Hydrochlorothiazide 12.5mg in Taiwanese Patients With Mild to Moderate Hypertension
NCT00133185 COMPLETED PHASE3
Safety Evaluation of Telmisartan Plus Hydrochlorothiazide in Patients With Mild-to-Moderate Hypertension
NCT02177487 COMPLETED PHASE3
J-TARGET,Japanese Telmisartan Study for Antihypertensive Good Effect in Long Term Observation
NCT00659581 COMPLETED
Telmisartan Plus Hydrochlorothiazide in Subjects With Mild-to-moderate Hypertension Who Failed to Respond to Telmisartan Monotherapy
NCT02177500 COMPLETED PHASE3
Additional Effect of A Life Style Program on Antihypertensive Treatment With Telmisartan
NCT01108796 COMPLETED
Investigating the Effect of Telmisartan (Micardis®) on the Average 24h Blood Pressure of Therapy-naive and Therapy-experienced Patients
NCT00879411 COMPLETED
Evaluation of the Effect of Telmisartan on Blood Pressure Control of High Risk Patients
NCT01108809 COMPLETED
Telmisartan and Hydrochlorothiazide Antihypertensive Treatment Study in High Sodium Intake Population
NCT02255253 COMPLETED NA
Post-Marketing Surveillance Study of Micardis® Plus in Patients With Hypertension
NCT02238275 COMPLETED
Telmisartan With or Without Hydrochlorothiazide (HCTZ) Compared With Losartan With or Without HCTZ in Mild to Moderate Hypertensive Patients
NCT02172586 COMPLETED PHASE4
Telmisartan With or Without Hydrochlorothiazide in Patients With Mild-to-moderate Hypertension
NCT02177435 COMPLETED PHASE3
Efficacy and Safety of Telmisartan and Losartan in Primary Hypertension
NCT02269176 COMPLETED PHASE3
Trial of Telmisartan 80 mg/HCTZ 12.5 mg and Telmisartan 40 mg/HCTZ 12.5 mg in Patients With Hypertension
NCT00326768 COMPLETED PHASE3
Study of Hypertensive Population Under Treatment With Telmisartan in Real Clinical Conditions With the Goal to Control Early Morning Blood Pressure Rise
NCT00946829 COMPLETED
Prospective Randomised Investigation of the Safety and Efficacy of Micardis® vs Ramipril Using ABPM
NCT00274612 COMPLETED PHASE4
Compare Efficacy and Safety of Telmisartan/Hydrochlorothiazide With Telmisartan/Hydrochlorothiazide Plus Amlodipine
NCT01911780 COMPLETED PHASE3